KNB.LSE Kanabo Group PLC

Healthcare Health Care Providers & Services London Exchange
0.0022 GBX
Close of May 26, 2026
0.2250 0.2250
Market cap
GBX 1.42M
P/E
-
P/B
0.24x
ROE
-88.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2024.

Is KNB.LSE undervalued?

Graham number

The Graham number of Kanabo Group PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kanabo Group PLC fundamental analysis

No fundamental analysis for Kanabo Group PLC yet.

Kanabo Group PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kanabo Group PLC

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It…

Full company profile